title: Incipient retinal vein occlusion following immunotherapy of periorbital basal cell carcinoma.
abstract: We report a case of retinal vein occlusion in a 54-year-old woman following treatment with topical imiquimod for a superficial basal cell carcinoma of the temple. Signs and symptoms resolved rapidly upon ceasing treatment. Although they are uncommon, it is important to recognise and promptly manage ophthalmic complications related to treatment with imiquimod in order to prevent serious sequelae such as macular oedema and neovascularization.
authors.affiliation: Department of Dermatology, Royal North Shore Hospital, Sydney, New South Wales, Australia. ehon8261@med.usyd.edu.au
authors.forename: Esther
authors.initials: E
authors.lastname: Hong
authors.forename: Alan
authors.initials: A
authors.lastname: Cooper
mesh_terms: D000276:Adjuvants, Immunologic / Q000009:adverse effects*; D000634:Aminoquinolines / Q000009:adverse effects*; D002280:Basal Cell Carcinoma / Q000188:drug therapy*; D005153:Facial Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D000077271:Imiquimod; D008875:Middle Aged; D012170:Retinal Vein Occlusion / Q000139:chemically induced*; D012878:Skin Neoplasms / Q000188:drug therapy*
chemical_list: D000276:Adjuvants, Immunologic; D000634:Aminoquinolines; D000077271:Imiquimod